Skip to main content

Table 5 Adverse events in patients

From: Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study

 

MTX (n = 69)

TwFH (n = 69)

TwFH + MTX (n = 69)

All

45 (65)

33 (48)

35 (51)

Nausea

18 (26)

9 (13)

17 (25)

Diarrhoea

3 (4)

2 (3)

1 (1)

Abdominal discomfort

13 (19)

9 (13)

11 (16)

Liver dysfunction

13 (19)

5 (7)

8 (12)

Serious Infection

5 (7)

0(0)

2 (3)

Baldness

3 (4)

2 (3)

5 (7)

Ulcer

8 (12)

1 (1)

6 (9)

Irregular menstruation

5 (7)

7 (10)

5 (7)

Anemia

7 (10)

1 (1)

6 (9)

Leucocytopenia

4 (6)

2 (3)

5 (7)

Palpitations

3 (4)

0 (0)

1 (1)

Headache

3 (4)

1 (1)

2 (3)

Fatigue

5 (7)

2 (3)

1 (1)

Weight loss

3 (4)

0 (0)

1 (1)

  1. MTX methotrexate, TwHF Tripterygium wilfordii Hook F
  2. Data are presented as number (percentage)